Skip to main content
Clinical Trials/NCT00757185
NCT00757185CompletedEarly Phase 1

Compromised Microcirculation in Women With Polycystic Ovary Syndrome

Yale University1 site in 1 country28 target enrollmentStarted: February 2008Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Early Phase 1
Status
Completed
Enrollment
28
Locations
1
Primary Endpoint
Skin blood flow and cutaneous vascular conductance

Study Overview

Brief Summary

The scientific aims of the study are to determine how peripheral microcirculatory responsiveness is altered in obese women with Polycystic Ovary Syndrome (PCOS) during local heating and to determine the mechanism for testosterone effects on peripheral microcirculatory responsiveness in women with PCOS.

Detailed Description

In these studies, we propose to use the skin as a relatively non-invasive model to examine cardiovascular and endothelial function in obese women with and without PCOS. Data have indicated an important role for testosterone in influencing the peripheral microcirculation. While testosterone can lead to vasodilation in the peripheral microcirculation in both men and in women without PCOS, testosterone appears to induce vasoconstriction in women with PCOS. The differential response between women with and without PCOS, and between men and women may be the result of differential ET-1 actions in the vessel, and regulated by the receptor subtype is involved in these actions.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
18 Years to 35 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Obese women (18-35) years with and without PCOS

Exclusion Criteria

  • Conditions that would preclude safe use of hormones

Arms & Interventions

2

Experimental

GnRH with Testosterone

Intervention: methyl testosterone (Drug)

1

Experimental

GNRH antagonist alone

Intervention: ganirelix acetate (Drug)

Outcomes

Primary Outcomes

Skin blood flow and cutaneous vascular conductance

Time Frame: 6 non consecutive days

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials